Related Experiment Video
Updated: Jan 8, 2026

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
Economic Evaluation of Therapeutic Drug Monitoring and Precision Dosing in Pediatrics: A Short Communication
Víctor E Lechuga-Noa1,2, Guillermo Federico Taboada3, Paulo Cáceres Guido3
1Cardiovascular Pharmacy, Instituto Nacional Cardiovascular-INCOR-EsSalud, Lima, Perú.
Background:
This scoping review evaluates the economic impact of therapeutic drug monitoring (TDM) and model-informed precision dosing (MIPD), incorporating clinical pharmacokinetics principles in pediatric populations.
Methods:
This study followed the PRISMA-ScR guidelines. From 1057 articles identified, 8 met inclusion criteria (5 retrospective studies and 3 Markov-based simulations) focusing on the following drugs: PEG-asparaginase, valproic acid, carbamazepine, phenytoin, phenobarbital, vancomycin, adalimumab, tobramycin, cyclosporine, and perampanel.
Results:
Most studies reported cost savings or improved cost-effectiveness with TDM-MIPD strategies. However, analyses were limited to direct medical costs, with little consideration of indirect or societal costs. Also, methodological heterogeneity limited direct comparisons.
Conclusions:
The lack of standardized methodologies and economic endpoints, along with potential underreporting of negative findings, restricts the generalizability of conclusions. Nevertheless, current evidence supports TDM-MIPD as a potentially cost-effective approach in pediatric pharmacotherapy.
More Related Videos
Related Concept Videos
Therapeutic Drug Monitoring: Drug Analysis Methods
Therapeutic Drug Monitoring: Overview and Classification
Pharmacokinetics in Pediatric Patients: Drug Excretion
Drug Dosing: Infants and Children
Therapeutic Drug Monitoring: Affecting Factors
Dosage Regimen: Individualization

